EFFECT OF ONCE-WEEKLY RIFAPENTINE AND ISONIAZID ON THE PHARMACOKINETICS OF TWICE-DAILY DORAVIRINE IN HEALTHY VOLUNTEERS.

被引：0
|
作者：
Lam, E. [1 ]
Zheng, R. [1 ]
Schaefer, J. [2 ]
Kraft, W. [1 ]
机构：
[1] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
[2] Sidney Kimmel Med Coll, Philadelphia, PA USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2020年 / 107卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PIII-009
引用
收藏
页码：S81 / S81
页数：1
相关论文
共 50 条
  • [31] DAPAGLIFLOZIN TWICE DAILY OR ONCE DAILY: EFFECT ON PHARMACOKINETICS AND URINARY GLUCOSE EXCRETION IN HEALTHY SUBJECTS
    Tang, W.
    Reele, S.
    Hamer-Maansson, J. E.
    Parikh, S.
    de Bruin, T. W.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S90 - S90
  • [32] Update of Recommendations for Use of Once-Weekly Isoniazid-Rifapentine Regimen to Treat Latent Mycobacterium tuberculosis Infection
    Borisov, Andrey S.
    Morris, Sapna Bamrah
    Njie, Gibril J.
    Winston, Carla A.
    Burton, Deron
    Goldberg, Stefan
    Woodruff, Rachel Yelk
    Allen, Leeanna
    LoBue, Philip
    Vernon, Andrew
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2018, 67 (25): : 723 - 726
  • [33] Pharmacokinetics of rifapentine at 600, 900, and 1,200 mg during once-weekly tuberculosis therapy
    Weiner, M
    Bock, N
    Peloquin, CA
    Burman, WJ
    Khan, A
    Vernon, A
    Zhao, Z
    Weis, S
    Sterling, TR
    Hayden, K
    Goldberg, S
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 169 (11) : 1191 - 1197
  • [34] Comparison of Pharmacokinetics and Pathology for Low-Dose Tacrolimus Once-Daily and Twice-Daily in Living Kidney Transplantation: Prospective Trial in Once-Daily Versus Twice-Daily Tacrolimus
    Tsuchiya, Tomohiro
    Ishida, Hideki
    Tanabe, Tatsu
    Shimizu, Tomokazu
    Honda, Kazuho
    Omoto, Kazuya
    Tanabe, Kazunari
    TRANSPLANTATION, 2013, 96 (02) : 198 - 204
  • [35] Safety and Pharmacokinetics of Escalating Daily Doses of the Antituberculosis Drug Rifapentine in Healthy Volunteers
    Dooley, K. E.
    Bliven-Sizemore, E. E.
    Weiner, M.
    Lu, Y.
    Nuermberger, E. L.
    Hubbard, W. C.
    Fuchs, E. J.
    Melia, M. T.
    Burman, W. J.
    Dorman, S. E.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 (05) : 881 - 888
  • [36] Pharmacokinetics and Pharmacodynamics of Twice Daily and Once Daily Regimens of Empagliflozin in Healthy Subjects
    Macha, Sreeraj
    Brand, Tobias
    Meinicke, Thomas
    Link, Jasniin
    Broedl, Uli C.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : 1789 - 1796
  • [37] Twice-daily to once-daily lopinavir/ritonavir pharmacokinetics-pharmacodynamics in pediatric patients
    Foissac, F.
    Blanche, S.
    Hirt, D.
    Treluyer, J. M.
    Urien, S.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2010, 24 : 60 - 60
  • [38] Effect of grapefruit juice on the pharmacokinetics of losartan in healthy volunteers.
    Zaidenstein, R
    Avni, B
    Dishi, V
    Gipps, M
    Soback, S
    Koren, M
    Simantov, R
    Golik, A
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 132 - 132
  • [39] EFFECT OF ADMINISTRATION TIME ON THE PHARMACOKINETICS OF TRIAZOLAM IN HEALTHY VOLUNTEERS.
    Morimoto, T.
    Imai, H.
    Suzaki, Y.
    Ohyama, T.
    Shimada, H.
    Kotegawa, T.
    Tsutsumi, K.
    Toyota, K.
    Tokuno, S.
    Matsumoto, K.
    Uemura, N.
    Nakano, S.
    Ohashi, K.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S57 - S57
  • [40] Pragmatic global dosing recommendations for the 3-month, once-weekly rifapentine and isoniazid preventive TB regimen in children
    Radtke, Kendra K.
    Hibma, Jennifer E.
    Hesseling, Anneke C.
    Savic, Rada M.
    EUROPEAN RESPIRATORY JOURNAL, 2021, 57 (01)
12345